PABVX
Price
$18.49
Change
-$0.11 (-0.59%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

PABVX vs VMVAX

Header iconPABVX vs VMVAX Comparison
Open Charts PABVX vs VMVAXBanner chart's image
Principal MidCap Value I R5
Price$18.49
Change-$0.11 (-0.59%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PABVX vs VMVAX Comparison Chart
Loading...
VS
PABVX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABVX is a Sell and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. PABVX (2.93B). VMVAX pays higher dividends than PABVX: VMVAX (2.14) vs PABVX (1.01). PABVX was incepted earlier than VMVAX: PABVX (20 years) vs VMVAX (13 years). PABVX is a more actively managed with annual turnover of: 49.90 vs. VMVAX (22.00). PABVX has a lower initial minimum investment than VMVAX: PABVX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. PABVX (21.15). VMVAX return over 5 years is better than : 48.82 vs. PABVX (37.02).
PABVXVMVAXPABVX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years13 years-
Gain YTD13.92514.94693%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.93B30.5B10%
Annual Yield % from dividends1.012.1447%
Returns for 1 year21.1525.3583%
Returns for 3 years5.8520.7128%
Returns for 5 years37.0248.8276%
Returns for 10 years24.13100.8824%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio